US Stock MarketDetailed Quotes

Gilead Sciences (GILD)

Watchlist

132.510
-0.540-0.41%

Trading May 14 15:20 ET

164.52BMarket Cap18.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gilead Sciences (GILD) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

4.39%6.96B

2.39%29.44B

4.69%7.92B

2.97%7.77B

1.84%7.08B

-0.28%6.67B

6.04%28.75B

6.40%7.57B

7.02%7.55B

5.36%6.95B

Operating revenue

4.39%6.96B

2.39%29.44B

4.69%7.92B

2.97%7.77B

1.84%7.08B

-0.28%6.67B

6.04%28.75B

6.40%7.57B

7.02%7.55B

5.36%6.95B

Cost of revenue

-6.17%1.45B

-0.27%6.23B

2.72%1.62B

-0.32%1.57B

-2.78%1.5B

-0.77%1.54B

-3.80%6.25B

-24.35%1.58B

0.58%1.57B

7.07%1.54B

Gross profit

7.57%5.52B

3.13%23.21B

5.21%6.3B

3.84%6.2B

3.16%5.58B

-0.14%5.13B

9.14%22.5B

19.19%5.99B

8.86%5.97B

4.89%5.41B

Operating expense

7.05%2.82B

-3.36%11.51B

-4.19%3.31B

-4.42%2.7B

4.69%2.86B

-8.91%2.64B

1.08%11.91B

15.70%3.46B

2.02%2.83B

-16.22%2.73B

Selling and administrative expenses

15.34%1.45B

-4.87%5.71B

-4.85%1.73B

-5.30%1.36B

-0.87%1.37B

-8.51%1.26B

-1.02%6B

14.94%1.82B

8.97%1.43B

-25.53%1.38B

-Selling and marketing expense

19.26%898M

2.00%3.52B

1.80%1.08B

-2.24%829M

7.33%864M

1.35%753M

5.53%3.45B

--1.06B

--848M

--805M

-General and administrative expense

9.50%553M

-14.17%2.19B

-14.10%652M

-9.74%528M

-12.41%501M

-20.09%505M

-8.71%2.55B

--759M

--585M

--572M

Research and development costs

-0.51%1.37B

-1.83%5.8B

-3.47%1.58B

-3.51%1.35B

10.36%1.49B

-9.28%1.38B

3.31%5.91B

16.55%1.64B

-4.26%1.4B

-3.98%1.35B

Operating profit

8.11%2.69B

10.43%11.7B

18.06%2.99B

11.26%3.5B

1.60%2.72B

11.21%2.49B

19.89%10.6B

24.31%2.53B

15.85%3.14B

41.03%2.68B

Net non-operating interest income expense

12.65%-145M

3.02%-675M

2.44%-160M

9.68%-168M

10.40%-181M

-13.70%-166M

-22.54%-696M

-9.33%-164M

-47.62%-186M

12.17%-202M

Non-operating interest income

1.06%95M

24.20%349M

11.76%95M

69.23%88M

108.57%73M

-12.96%94M

-25.27%281M

-16.67%85M

-50.94%52M

--35M

Non-operating interest expense

-7.69%240M

4.81%1.02B

2.41%255M

7.56%256M

7.17%254M

2.36%260M

3.50%977M

-1.19%249M

2.59%238M

3.04%237M

Other net income (expense)

104.89%33M

86.64%-1.23B

-273.13%-750M

115.59%312M

73.19%-115M

89.74%-675M

-552.73%-9.21B

14.10%-201M

-643.87%-2B

-410.71%-429M

Gain on sale of security

133.33%142M

264.60%451M

300.79%253M

87.21%483M

136.22%142M

-2,942.86%-426M

-64.07%-274M

-166.67%-126M

253.57%258M

---392M

Special income (charges)

57.71%-107M

81.20%-1.68B

-1,156.25%-1.01B

92.46%-170M

-560.53%-251M

96.14%-253M

-624.57%-8.93B

81.18%-80M

-2,378.02%-2.26B

83.90%-38M

-Less：Restructuring and merger&acquisition

----

-27.47%66M

----

225.00%91M

----

-Less:Other special charges

-57.71%107M

-78.04%1.02B

5,000.00%539M

-66.34%170M

60.53%61M

-93.88%253M

303.72%4.66B

-103.17%-11M

454.95%505M

-83.90%38M

-Write off

----

-85.89%590M

--400M

--0

--190M

--0

8,260.00%4.18B

--0

--1.75B

--0

Other non- operating income (expenses)

-150.00%-2M

50.00%-1M

-60.00%2M

75.00%-1M

-700.00%-6M

200.00%4M

81.82%-2M

150.00%5M

60.00%-4M

-99.34%1M

Income before tax

56.46%2.58B

1,319.71%9.8B

-4.11%2.08B

280.86%3.64B

18.31%2.43B

136.76%1.65B

-89.94%690M

31.09%2.17B

-58.76%956M

29.28%2.05B

Income tax

67.37%559M

509.48%1.29B

-127.27%-105M

298.32%589M

6.85%468M

206.03%334M

-83.08%211M

62.45%385M

-303.42%-297M

-20.22%438M

Net income

53.69%2.02B

1,672.92%8.51B

22.43%2.18B

143.58%3.05B

21.44%1.96B

131.53%1.32B

-91.45%480M

25.83%1.78B

-42.31%1.25B

55.34%1.61B

Net income continuous Operations

53.69%2.02B

1,676.62%8.51B

22.50%2.18B

143.58%3.05B

21.42%1.96B

131.53%1.32B

-91.46%479M

25.85%1.78B

-42.31%1.25B

55.44%1.62B

Minority interest income

Net income attributable to the parent company

53.69%2.02B

1,672.92%8.51B

22.43%2.18B

143.58%3.05B

21.44%1.96B

131.53%1.32B

-91.53%480M

24.77%1.78B

-42.52%1.25B

54.45%1.61B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

53.69%2.02B

1,672.92%8.51B

22.43%2.18B

143.58%3.05B

21.44%1.96B

131.53%1.32B

-91.53%480M

24.77%1.78B

-42.52%1.25B

54.45%1.61B

Basic earnings per share

53.77%1.63

1,700.00%6.84

23.08%1.76

146.00%2.46

21.71%1.57

131.74%1.06

-91.63%0.38

24.35%1.43

-42.86%1

53.57%1.29

Diluted earnings per share

54.81%1.61

1,684.21%6.78

22.54%1.74

143.00%2.43

20.93%1.56

131.14%1.04

-91.56%0.38

24.56%1.42

-42.20%1

55.42%1.29

Dividend per share

3.80%0.82

2.60%3.16

2.60%0.79

2.67%3.08

2.67%0.77

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	4.39%6.96B	2.39%29.44B	4.69%7.92B	2.97%7.77B	1.84%7.08B	-0.28%6.67B	6.04%28.75B	6.40%7.57B	7.02%7.55B	5.36%6.95B
Operating revenue	4.39%6.96B	2.39%29.44B	4.69%7.92B	2.97%7.77B	1.84%7.08B	-0.28%6.67B	6.04%28.75B	6.40%7.57B	7.02%7.55B	5.36%6.95B
Cost of revenue	-6.17%1.45B	-0.27%6.23B	2.72%1.62B	-0.32%1.57B	-2.78%1.5B	-0.77%1.54B	-3.80%6.25B	-24.35%1.58B	0.58%1.57B	7.07%1.54B
Gross profit	7.57%5.52B	3.13%23.21B	5.21%6.3B	3.84%6.2B	3.16%5.58B	-0.14%5.13B	9.14%22.5B	19.19%5.99B	8.86%5.97B	4.89%5.41B
Operating expense	7.05%2.82B	-3.36%11.51B	-4.19%3.31B	-4.42%2.7B	4.69%2.86B	-8.91%2.64B	1.08%11.91B	15.70%3.46B	2.02%2.83B	-16.22%2.73B
Selling and administrative expenses	15.34%1.45B	-4.87%5.71B	-4.85%1.73B	-5.30%1.36B	-0.87%1.37B	-8.51%1.26B	-1.02%6B	14.94%1.82B	8.97%1.43B	-25.53%1.38B
-Selling and marketing expense	19.26%898M	2.00%3.52B	1.80%1.08B	-2.24%829M	7.33%864M	1.35%753M	5.53%3.45B	--1.06B	--848M	--805M
-General and administrative expense	9.50%553M	-14.17%2.19B	-14.10%652M	-9.74%528M	-12.41%501M	-20.09%505M	-8.71%2.55B	--759M	--585M	--572M
Research and development costs	-0.51%1.37B	-1.83%5.8B	-3.47%1.58B	-3.51%1.35B	10.36%1.49B	-9.28%1.38B	3.31%5.91B	16.55%1.64B	-4.26%1.4B	-3.98%1.35B
Operating profit	8.11%2.69B	10.43%11.7B	18.06%2.99B	11.26%3.5B	1.60%2.72B	11.21%2.49B	19.89%10.6B	24.31%2.53B	15.85%3.14B	41.03%2.68B
Net non-operating interest income expense	12.65%-145M	3.02%-675M	2.44%-160M	9.68%-168M	10.40%-181M	-13.70%-166M	-22.54%-696M	-9.33%-164M	-47.62%-186M	12.17%-202M
Non-operating interest income	1.06%95M	24.20%349M	11.76%95M	69.23%88M	108.57%73M	-12.96%94M	-25.27%281M	-16.67%85M	-50.94%52M	--35M
Non-operating interest expense	-7.69%240M	4.81%1.02B	2.41%255M	7.56%256M	7.17%254M	2.36%260M	3.50%977M	-1.19%249M	2.59%238M	3.04%237M
Other net income (expense)	104.89%33M	86.64%-1.23B	-273.13%-750M	115.59%312M	73.19%-115M	89.74%-675M	-552.73%-9.21B	14.10%-201M	-643.87%-2B	-410.71%-429M
Gain on sale of security	133.33%142M	264.60%451M	300.79%253M	87.21%483M	136.22%142M	-2,942.86%-426M	-64.07%-274M	-166.67%-126M	253.57%258M	---392M
Special income (charges)	57.71%-107M	81.20%-1.68B	-1,156.25%-1.01B	92.46%-170M	-560.53%-251M	96.14%-253M	-624.57%-8.93B	81.18%-80M	-2,378.02%-2.26B	83.90%-38M
-Less：Restructuring and merger&acquisition	----	-27.47%66M	----	----	----	----	225.00%91M	----	----	----
-Less:Other special charges	-57.71%107M	-78.04%1.02B	5,000.00%539M	-66.34%170M	60.53%61M	-93.88%253M	303.72%4.66B	-103.17%-11M	454.95%505M	-83.90%38M
-Write off	----	-85.89%590M	--400M	--0	--190M	--0	8,260.00%4.18B	--0	--1.75B	--0
Other non- operating income (expenses)	-150.00%-2M	50.00%-1M	-60.00%2M	75.00%-1M	-700.00%-6M	200.00%4M	81.82%-2M	150.00%5M	60.00%-4M	-99.34%1M
Income before tax	56.46%2.58B	1,319.71%9.8B	-4.11%2.08B	280.86%3.64B	18.31%2.43B	136.76%1.65B	-89.94%690M	31.09%2.17B	-58.76%956M	29.28%2.05B
Income tax	67.37%559M	509.48%1.29B	-127.27%-105M	298.32%589M	6.85%468M	206.03%334M	-83.08%211M	62.45%385M	-303.42%-297M	-20.22%438M
Net income	53.69%2.02B	1,672.92%8.51B	22.43%2.18B	143.58%3.05B	21.44%1.96B	131.53%1.32B	-91.45%480M	25.83%1.78B	-42.31%1.25B	55.34%1.61B
Net income continuous Operations	53.69%2.02B	1,676.62%8.51B	22.50%2.18B	143.58%3.05B	21.42%1.96B	131.53%1.32B	-91.46%479M	25.85%1.78B	-42.31%1.25B	55.44%1.62B
Minority interest income		0	0	0	0	0	0	0	0	0
Net income attributable to the parent company	53.69%2.02B	1,672.92%8.51B	22.43%2.18B	143.58%3.05B	21.44%1.96B	131.53%1.32B	-91.53%480M	24.77%1.78B	-42.52%1.25B	54.45%1.61B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	53.69%2.02B	1,672.92%8.51B	22.43%2.18B	143.58%3.05B	21.44%1.96B	131.53%1.32B	-91.53%480M	24.77%1.78B	-42.52%1.25B	54.45%1.61B
Basic earnings per share	53.77%1.63	1,700.00%6.84	23.08%1.76	146.00%2.46	21.71%1.57	131.74%1.06	-91.63%0.38	24.35%1.43	-42.86%1	53.57%1.29
Diluted earnings per share	54.81%1.61	1,684.21%6.78	22.54%1.74	143.00%2.43	20.93%1.56	131.14%1.04	-91.56%0.38	24.56%1.42	-42.20%1	55.42%1.29
Dividend per share	3.80%0.82	2.60%3.16	2.60%0.79	2.60%0.79	2.60%0.79	2.60%0.79	2.67%3.08	2.67%0.77	2.67%0.77	2.67%0.77
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm